je.st
news
Tag: gilead sciences
Gilead Sciences to Present at the Morgan Stanley Global Healthcare...
2015-09-16 02:37:40| Biotech - Topix.net
Gilead Sciences, Inc. today announced that John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 16at 1:05 p.m. Eastern Time. The audio portion of the fireside chat will be accessible live through the company's Investors page at www.gilead.com/investors .
Tags: present
global
sciences
morgan
Gilead Sciences to Release Second Quarter 2015 Financial Results on...
2015-07-22 22:30:04| Biotech - Topix.net
Gilead Sciences, Inc. announced today that its second quarter 2015 financial results will be released on Tuesday, July 28, at 4:05 p.m. Eastern Time. At 4:30 p.m. Eastern Time, Gilead's management will host a conference call to discuss the company's financial results for the second quarter 2015 and provide a general business update.
Tags: results
release
financial
sciences
How Gilead Sciences Is Gouging Hepatitis C Patients, $1,000 a Pill
2015-06-21 20:06:31| Biotech - Topix.net
A new wave of hepatitis C drugs is all the rage. But while these new pills boast cure rates of 90 percent in less time than their predecessors, their prices are causing rage.
Tags: sciences
patients
pill
hepatitis
Gilead Sciences to Present at Two Upcoming Investor Conferences on...
2015-06-09 01:57:35| Biotech - Topix.net
Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from two upcoming investor conferences: the Goldman Sachs 36th Annual Global Healthcare Conference in Rancho Palos Verdes and the William Blair 35th Annual Growth Stock Conference in Chicago. John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company at the Goldman Sachs conference on Tuesday, June 9 at 10:00 a.m. Pacific Time.
Tags: on
present
sciences
upcoming
Gilead Sciences Will Do Some Deals, Surprise to the Upside
2015-06-03 18:06:12| Logistics - Topix.net
RBC's Michael Yee and team recommend investors buy Gilead Sciences , even as the biotech sector enters a period of seasonal choppiness. They explain why: Biotech has rallied and is setting up to test resistance for the third time with the Nasdaq Biotechnology Index around 3850.
Tags: the
deals
sciences
surprise